BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.00K | 58.00K | 71.00K | 428.00K | 468.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.00K | 58.00K | 71.00K | 428.00K | 468.00K |
| Cost of Revenue | 1.70M | 1.42M | 4.13M | 5.07M | 6.58M |
| Gross Profit | -1.70M | -1.36M | -4.06M | -4.64M | -6.12M |
| SG&A Expenses | 3.78M | 3.67M | 3.71M | 3.97M | 4.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.46M | 8.06M | 7.84M | 9.03M | 10.88M |
| Operating Income | -8.45M | -8.00M | -7.76M | -8.61M | -10.41M |
| Income Before Tax | -8.39M | -7.95M | -7.72M | -8.56M | -10.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.39 | -7.95 | -7.72 | -8.56 | -10.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.39M | -7.95M | -7.72M | -8.56M | -10.34M |
| EBIT | -8.45M | -8.00M | -7.76M | -8.61M | -10.41M |
| EBITDA | -8.39M | -7.93M | -7.69M | -8.53M | -10.33M |
| EPS Basic | -2.58 | -3.34 | -4.22 | -5.40 | -7.04 |
| Normalized Basic EPS | -1.61 | -2.09 | -2.64 | -3.37 | -4.40 |
| EPS Diluted | -3.08 | -3.85 | -4.22 | -5.40 | -7.04 |
| Normalized Diluted EPS | -1.61 | -2.09 | -2.64 | -3.37 | -4.40 |
| Average Basic Shares Outstanding | 13.93M | 10.97M | 7.88M | 6.50M | 5.98M |
| Average Diluted Shares Outstanding | 13.93M | 10.97M | 7.88M | 6.50M | 5.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |